CXCL10 and early-onset autosomal dominant Alzheimer disease: In Alzheimer’s patients, while CXCR3 expression level remained unaltered, its ligand CXCL10 was found to be upregulated in astrocytes, which remained associated with senile plaques, characteristic of Alzheimer’s disease (Xia et al., 2000).